Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Departments of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518009, P. R. China.
Adv Sci (Weinh). 2023 Mar;10(7):e2204565. doi: 10.1002/advs.202204565. Epub 2023 Jan 29.
Lymph node metastasis, the leading cause of mortality in esophageal squamous carcinoma (ESCC) with a highly complex tumor microenvironment, remains underexplored. Here, the transcriptomes of 85 263 single cells are analyzed from four ESCC patients with lymph node metastases. Strikingly, it is observed that the metastatic microenvironment undergoes the emergence or expansion of interferon induced IFIT3 T, B cells, and immunosuppressive cells such as APOC1 APOE macrophages and myofibroblasts with highly expression of immunoglobulin genes (IGKC) and extracellular matrix component and matrix metallopeptidase genes. A poor-prognostic epithelial-immune dual expression program regulating immune effector processes, whose activity is significantly enhanced in metastatic malignant epithelial cells and enriched in CD74 CXCR4 and major histocompatibility complex (MHC) class II genes upregulated malignant epithelia cells is discovered. Comparing with primary tumor, differential intercellular communications of metastatic ESCC microenvironment are revealed and furtherly validated via multiplexed immunofluorescence and immunohistochemistry staining, which mainly rely on the crosstalk of APOC1 APOE macrophages with tumor and stromal cell. The data highlight potential molecular mechanisms that shape the lymph-node metastatic microenvironment and may inform drug discovery and the development of new strategies to target these prometastatic nontumor components for inhibiting tumor growth and overcoming metastasis to improve clinical outcomes.
淋巴结转移是导致食管鳞癌(ESCC)患者死亡的主要原因,其肿瘤微环境非常复杂,但目前对此研究还不够充分。本研究对 4 名淋巴结转移的 ESCC 患者的 85263 个单细胞转录组进行了分析。研究结果表明,转移性微环境中出现或扩大了干扰素诱导的 IFIT3+T 细胞、B 细胞以及免疫抑制细胞,如 APOC1+APOE+巨噬细胞和肌成纤维细胞,这些细胞高表达免疫球蛋白基因(IGKC)和细胞外基质成分及基质金属蛋白酶基因。研究还发现了一个预后不良的上皮-免疫双重表达程序,该程序调节免疫效应过程,其在转移性恶性上皮细胞中的活性显著增强,并在 CD74+CXCR4+和主要组织相容性复合体(MHC)II 类基因上调的恶性上皮细胞中富集。与原发性肿瘤相比,转移性 ESCC 微环境的细胞间通讯存在差异,通过多重免疫荧光和免疫组化染色进一步验证,这主要依赖于 APOC1+APOE+巨噬细胞与肿瘤和基质细胞的相互作用。这些数据突显了塑造淋巴结转移微环境的潜在分子机制,可能为药物发现和开发新策略提供信息,以针对这些促进转移的非肿瘤成分进行治疗,从而抑制肿瘤生长和克服转移,改善临床治疗效果。